Rachel L. Clement

Rachel L. Clement

Auto-generated profile, based on publicly available information

Rachel L. Clement

Institute for Immunology and Immune Health, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RCRachel L. Clement
Rachel L. Clement
JDJoe Daccache
Joe Daccache
MMMostafa T. Mohammed
Mostafa T. Mohammed
ADAlos Diallo
Alos Diallo
BBBruce R. Blazar
Bruce R. Blazar
PSPeter T. Sage
Peter T. Sage

1 December 2020 in Immunity
Verified
Journal Article
Closed access
JTJacob A. Turner
Jacob A. Turner
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
SWSen Wang
Sen Wang
MRMagali Noval Rivas
Magali Noval Rivas
AAAzza Abdel-Gadir
Azza Abdel-Gadir
TCTalal A. Chatila
Talal A. Chatila

31 January 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SHShenda Hou
Shenda Hou
RCRachel L. Clement
Rachel L. Clement
ADAlos Diallo
Alos Diallo
BBBruce R. Blazar
Bruce R. Blazar
ARAlexander Y. Rudensky
Alexander Y. Rudensky
PSPeter T. Sage
Peter T. Sage
Follicular regulatory T (Tfr) cells are a regulatory T cell subset that controls antibody production by inhibiting T follicular helper (Tfh)–mediated help to B cells. Tfh and Tfr cells possess opposing functions suggesting unique programming. Here we elucidated the transcriptional program controlling Tfr suppressive function. We found that Tfr cells have a program for suppressive function fine-tuned by tissue microenvironment. The transcription factor FoxP3 and chromatin-modifying enzyme EZH2 are essential for this transcriptional program but regulate the program in distinct ways. FoxP3 modifies the Tfh program to induce a Tfr-like functional state, demonstrating that Tfr cells coopt the Tfh program for suppression. Importantly, we identified a Tfr cell population that loses the Tfr program to become “ex-Tfr” cells with altered functionality. These dysfunctional ex-Tfr cells may have roles in modulating pathogenic antibody responses. Taken together, our studies reveal mechanisms controlling the Tfr transcriptional program and how failure of these mechanisms leads to dysfunctional Tfr cells.

1 February 2022 in Cell Reports
Verified
Journal Article
Open access
CCCecilia B. Cavazzoni
Cecilia B. Cavazzoni
BHBenjamin L. Hanson
Benjamin L. Hanson
MPManuel A. Podestà
Manuel A. Podestà
EBElsa D. Bechu
Elsa D. Bechu
RCRachel L. Clement
Rachel L. Clement
PSPeter T. Sage
Peter T. Sage
Follicular helper T (Tfh) cells promote, whereas follicular regulatory T (Tfr) cells restrain, germinal center (GC) reactions. However, the precise roles of these cells in the complex GC reaction remain poorly understood. Here, we perturb Tfh or Tfr cells after SARS-CoV-2 spike protein vaccination in mice. We find that Tfh cells promote the frequency and somatic hypermutation (SHM) of Spike-specific GC B cells and regulate clonal diversity. Tfr cells similarly control SHM and clonal diversity in the GC but do so by limiting clonal competition. In addition, deletion of Tfh or Tfr cells during primary vaccination results in changes in SHM after vaccine boosting. Aged mice, which have altered Tfh and Tfr cells, have lower GC responses, presenting a bimodal distribution of SHM. Together, these data demonstrate that GC responses to SARS-CoV-2 spike protein vaccines require a fine balance of positive and negative follicular T cell help to optimize humoral immunity.

24 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPManuel Alfredo Podestà
Manuel Alfredo Podestà
CCCecilia B. Cavazzoni
Cecilia B. Cavazzoni
BHBenjamin L. Hanson
Benjamin L. Hanson
EBElsa D. Bechu
Elsa D. Bechu
GRGaryfallia Ralli
Garyfallia Ralli
PSPeter T. Sage
Peter T. Sage
Follicular helper T (Tfh) cells are essential for the formation of high affinity antibodies after vaccination or infection. Although the signals responsible for initiating Tfh differentiation from naïve T cells have been studied, the signals controlling sequential developmental stages culminating in optimal effector function are not well understood. Here we use fate mapping strategies for the cytokine IL-21 to uncover sequential developmental stages of Tfh differentiation including a progenitor-like stage, a fully developed effector stage and a post-effector Tfh stage that maintains transcriptional and epigenetic features without IL-21 production. We find that progression through these stages are controlled intrinsically by the transcription factor FoxP1 and extrinsically by follicular regulatory T cells. Through selective deletion of Tfh stages, we show that these cells control antibody dynamics during distinct stages of the germinal center reaction in response to a SARS-CoV-2 vaccine. Together, these studies demonstrate the sequential phases of Tfh development and how they promote humoral immunity.

19 May 2025 in Allergy
Verified
Journal Article
Open access
RCRachel L. Clement
Rachel L. Clement
JDJulie Dilollo
Julie Dilollo
EREric M. Rodríguez‐López
Eric M. Rodríguez‐López
CGCleandre M. Guerrier
Cleandre M. Guerrier
DHDavid Andrew Hill
David Andrew Hill
Background: Eosinophilic Esophagitis (EoE) is a chronic food allergy that causes esophageal inflammation and fibrosis and manifests with symptoms of reflux, chest pain, swallowing difficulty, and food impactions. Though the prevalence of EoE is increasing by ~15% each year, our understanding of EoE immunopathology is limited. A noted feature of EoE is the presence of food‐specific IgG4 antibodies in the circulation and esophageal tissue. Production of IgG4 is confined to IL‐10+ B cells (Bregs) in other allergic diseases, suggesting Bregs may be present in EoE.Methods: We examined circulating Bregs in patients with EoE milk allergy. In parallel, we performed mechanistic investigations of the role of Bregs in a murine model of food‐antigen‐dependent EoE. Flow cytometry and histologic analyses were used to assess esophageal and draining lymph node immune cells, and in vitro assays were used to evaluate Breg functional capacity.Results: Breg frequency was reduced in both EoE milk allergic subjects and an EoE disease model. Murine Breg suppressive capacity was impaired during EoE‐like inflammation. Inducible deletion of Breg‐derived IL‐10 worsened EoE‐like inflammation, while adoptive transfer of IL‐10 sufficient Bregs suppressed DC activation and improved esophageal eosinophilia. IFNγ was sufficient to suppress Breg expansion and IL‐10 production in vitro and contributed to Breg dysfunction and esophageal inflammation in vivo.Conclusion: Bregs play an immunoregulatory role during EoE by controlling esophageal eosinophilia but are functionally impaired due to IFNγ‐mediated signaling. These findings have important implications for understanding EoE's etiology and implementing future therapies that target IFNγ.